KG Beteiligungs Co Gmbh Bioventures Mpm IV Net Worth & Insider Trades

KG Beteiligungs Co Gmbh Bioventures Mpm IV Pacira Pharmaceuticals, Inc

As of March 13, 2013

What is KG Beteiligungs Co Gmbh Bioventures Mpm IV's Net Worth?

The current estimated net worth of Pacira Pharmaceuticals, Inc's KG Beteiligungs Co Gmbh Bioventures Mpm IV is estimated to be about $283.64M . KG Beteiligungs Co Gmbh Bioventures Mpm IV owns about 2,790,479 units of Pacira Pharmaceuticals, Inc common stock. In the last 2 years at Pacira Pharmaceuticals, Inc, KG Beteiligungs Co Gmbh Bioventures Mpm IV has sold an estimated value of $13.93M worth.

What is KG Beteiligungs Co Gmbh Bioventures Mpm IV's Past Insider Trading?

KG Beteiligungs Co Gmbh Bioventures Mpm IV's largest purchase order was 2,735,961 units , worth over $3.75M on February 10, 2011. KG Beteiligungs Co Gmbh Bioventures Mpm IV's largest sale order was 500,000 units , worth over $13.93M on March 13, 2013. In total, KG Beteiligungs Co Gmbh Bioventures Mpm IV has made about 3 transactions over 2 years of their time at Pacira Pharmaceuticals, Inc. KG Beteiligungs Co Gmbh Bioventures Mpm IV usually trades in February, March and November, with the busiest year in 2011.

MPM BioVentures IV QP LP, Paul James Scopa, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, MPM Asset Management Investors BV LLC, KG Beteiligungs Co GmbH BioVentures MPM IV, Todd Foley, John Vort Vander

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is KG Beteiligungs Co Gmbh Bioventures Mpm IV's' Mailing Address?

  • Mailing address is The John Hancock Tower 200 Clarendon Street, 54th Floor Boston MA 02116 MA

What are Pacira Pharmaceuticals, Inc's Past Insider Trades?

Pacira Pharmaceuticals, Inc's most recent insider trade came on August 5, 2022 by Roy Winston who sold 476 units worth $26.51K . In the last 10 years, insiders at Pacira Pharmaceuticals, Inc have sold an estimated value of $407.86M and bought an estimated value of $120.24M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are David Stack, CEO and Chairman,  Andreas Wicki, Director,  and Bullaro Lauren Riker, Senior Vice President .

Pacira BioSciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1